GIUFFRE', Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 4.365
EU - Europa 3.364
AS - Asia 691
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 8.426
Nazione #
US - Stati Uniti d'America 4.360
IE - Irlanda 1.007
SE - Svezia 926
CN - Cina 621
UA - Ucraina 412
DE - Germania 289
IT - Italia 211
FI - Finlandia 177
GB - Regno Unito 143
PL - Polonia 88
IN - India 50
BE - Belgio 46
AT - Austria 30
RU - Federazione Russa 21
VN - Vietnam 12
FR - Francia 10
CA - Canada 5
IR - Iran 4
BR - Brasile 3
EU - Europa 2
IQ - Iraq 2
PT - Portogallo 2
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
JP - Giappone 1
TW - Taiwan 1
Totale 8.426
Città #
Dublin 1.007
Chandler 930
Jacksonville 902
Nyköping 444
Beijing 297
Ashburn 193
Princeton 186
Ann Arbor 179
Cambridge 172
Dearborn 158
Medford 140
Des Moines 138
Boardman 117
Warsaw 86
Messina 68
New York 55
Jinan 51
Lancaster 49
Brussels 46
Woodbridge 43
Nanjing 38
Wilmington 38
Bremen 30
Vienna 30
Shenyang 29
San Mateo 26
Hebei 25
Hangzhou 24
Pune 19
Haikou 18
Ningbo 18
Taizhou 18
Tianjin 17
Houston 15
Hyderabad 14
Los Angeles 13
Dong Ket 12
Nanchang 12
Washington 12
Norwalk 11
Falls Church 10
Auburn Hills 9
Changsha 9
Fuzhou 9
Jiaxing 8
Leawood 8
Mumbai 8
Reggio Calabria 8
Guangzhou 7
Genova 6
Helsinki 6
Mountain View 6
Rome 6
Saint Petersburg 6
Seattle 6
Augusta 5
Catanzaro 5
Lanzhou 5
Taiyuan 5
Zhengzhou 5
Redwood City 4
Clearwater 3
Edinburgh 3
Naples 3
Pieve di Soligo 3
São Paulo 3
Tappahannock 3
Ardabil 2
Hefei 2
Lappeenranta 2
Lisbon 2
Lissone 2
Milan 2
Montebelluna 2
Najaf 2
Nicosia 2
Novokuznetsk 2
Redmond 2
Riva 2
Siracusa 2
Strasbourg 2
Wroclaw 2
Ascoli Piceno 1
Austin 1
Bari 1
Boston 1
Caltagirone 1
Concordia Sulla Secchia 1
Cormeilles-en-Parisis 1
Cupertino 1
Easton 1
Foggia 1
Fredericton 1
Henderson 1
Hillsdale 1
Ivry-sur-Seine 1
Kemerovo 1
Kunming 1
London 1
Longueuil 1
Totale 5.887
Nome #
Confronto tra le anomalie citologiche e colposcopiche e il Test per la tipizzazione dell’HPV per la prevenzione del cervicocarcinoma in una popolazione adolescenziale della città di Messina. 95
Human epidermal growth factor receptor 2 status in gastric carcinomas with distinctive prevalent cribriform component 95
Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening 85
Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial 82
Detection and genotyping of human papillomavirus in gynaecologic outpatients of Messina, eastern Sicily, Italy. 81
HER-2 overexpression in advanced node-positive gastric carcinomas: is there any relationship with other clinico-pathological histoprognostic parameters? 75
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications. 74
Preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes for the assessment of metastasis risk in breast cancer (BC). 73
Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas. 73
Lactoferrin expression in colorectal cancer: relationships with proliferation indices and survival. 72
BRAF mutation testing on melanoma brain metastases 72
Relationship between the presence of high risk HPV DNA and proliferation rate in cervical intraepithelial neoplasia 71
Adiponectin receptors expression is associated with an intestinal histotype and a longer survival in gastric carcinoma. 69
Inusuale localizzazione leucemica a sede mammaria 69
Unexpected cytological diagnosis of two cases of echinococcosis. 68
Prognostic significance of standardized AgNor analysis in early and advanced gastric carcinomas. 67
HER-2 overexpression in unusual histotypes of gastric carcinomas. 67
Immunohistochemical evidence of metallothionein in neoplasms of liver, gallbladder and pancreas 66
An immunohistochemical investigation of pre-metastatic niche (PMN) in node-negative invasive breast carcinomas 65
Immunohistochemical study of HER-2 overexpression in indolent gastric carcinomas. 65
Actinic keratosis associated with squamous and basal cell carcinomas: an evaluation of neoplastic progression by a standardized AgNOR analysis. 64
BRAF mutation testing on melanoma brain metastases 63
Human papillomavirus typing in gynaecologic outpatients in Messina, Italy. 63
AgNOR quantity as a prognostic tool in hyperplastic and neoplastic parathyroid glands 62
Immunohistochemical expression of autophagy-related proteins in advanced tubular gastric adenocarcinomas and its implications 62
Analysis of genomic low copy number DNA from cells harvested by laser-microdissection 60
Metastasis risk assessment in breast cancer (BC): a preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes 60
AgNOR quantity in actinic keratosis and squamous cell carcinoma of the skin 59
Immunohistochemical demonstration of metallothionein in eyes with choroidal melanomas 59
Actinic keratosis associated with squamous and basal cell carcinomas: an evaluation of neoplastic progression by a standardized AgNOR analysis. 59
Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypotheses. 58
L'angiodisplasia del tenue, una causa rara di emorragia digestiva. 58
Human Papillomavirus Types Distribution in Eastern Sicilian Females with cervical lesions. A Correlation with Colposcopic and Histological Findings. 58
HER2 analysis in sporadic thyroid cancer of follicular cell origin 58
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 58
Clearance and persistence of human papillomavirus infections in patients with lesions of the cervix 57
Immunoexpression of cyclooxygenase (COX)-2 in long-standing ulcerative colitis. 57
Microvessels density evaluation in human meningiomas: an immunohistochemical investigation by the specific marker for neoangiogenesis CD105 (Endoglin). 56
Rilievi immunoistochimici sull'antigene CA 19-9 nei carcinomi della colecisti. 56
Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease 55
Caveolin-1 in meningiomas: expression and clinico-pathological correlations 55
KRAS mutation testing on endoscopic biopsy of primary colorectal cancer 55
Le cheratosi attiniche. Classificazione istopatologica 54
Nucleolar organizer regions (NORs) in dysplastic and neoplastic epithelial lesions of the conjunctiva 54
Analisi immunoistochimica dell'espressione dlel'epidermal growth factor receptor (EGFR) e di HER2 nel carcinoma midollare della tiroide (MCT). 54
Immunohistochemical and biomolecular aspects in craniopharyngiomas: is there any suggestion to improve their treatment? 54
AgNOR analysis of gastric carcinoids. 53
A survey of laser-assisted microdissection systems in pathologic and forensic applications. 53
Immunohistochemical expression of metallothionein in primary hepatocellular carcinoma and liver metastases 52
Identification of Lf mRNA isoforms from human neoplastic cells harvested by laser microdissection. 52
Caveolina-1 nel carcinoma gastrico e nella mucosa gastrica normale adiacente: studio immunoistochimico e valutazioni istopatogenetiche. 52
Heterogeneity of KRAS mutational status in colorectal adenocarcinomas with a mucinous component 52
The immunoexpression of Tn, SIALYL-Tn and T antigens in chronic active gastritis in relation to Helicobacter pylori infection 51
Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry 51
Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes? 51
Extended RAS mutation testing on wild-type KRAS exon 2 metastatic colorectal cancer. 51
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 51
Immunolocalization of lactoferrin in surgically resected pigmented skin lesions 50
Relationship between HER2 status and proliferation rate in breast cancer assessed by immunohistochemistry, fluorescence in situ hybridisation and standardised AgNOR analysis 50
Discordance Rate of HER2 Status in Primary Gastric Cancer and Synchronous Lymph Node Metastases: Its Impact on Therapeutic Decision and Clinical Management 50
Expression of lactoferrin mRNA in human breast cancer cells selected by laser-microdissection. 50
AgNOR quantity in actinic keratosis and squamous cell carcinoma of the skin. 49
Heterogeneity of K-Ras mutation status in colorectal adenocarcinomas with a mucinous component. 49
BRAF status in papillary microcarcinomas of the thyroid gland: A brief review 49
Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas: a Sicilian multicentric retrospective analysis. 49
Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas 48
The application of AgNOR technique on glycol-methacrylate embedded human normal and pathological tissues. 48
The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. 48
null 48
Laser microdissection and DNA typing of cells from single hair follicles 47
Immunoespressione delle proteine del mismatch repair ed analisi dei microsatelliti mediante microdissezione in adenomi colo-rettali insorti in pazienti con HNPCC 47
Immunolocalization of lactoferrin in pigmented lesions of the skin. 47
MMR proteins immunoexpression and microsatellite analysis by laser-microdissection in HNPCC-associated adenomas 46
Immunohistochemical detection of metallothionein in carcinomatous and normal human gastric mucosa 46
Molecular diagnostics of cancer disposition in adenomas of HNPCC patients. The importance of laser-microdissection 45
Laser-assisted microdissection in the analysis of microsatellite instability 45
Immunohistochemical expression of pS2 protein in transitional cell bladder carcinomas. 45
AgNOR analysis of actinic keratosis basal and squamous cell carcinomas of the skin. 45
Morphometric analysis of AgNORs in uveal malignant melanoma 44
The AgNOR quantity as prognostic parameter in choroidal melanomas: a standardised analysis 44
PCNA/cyclin expression in breast carcinomas: its relationship with Ki-67, ER, PgR immunostainings and clinico-pathological aspects. 44
Microsatellite analysis in adenomas presenting in patients affected by HNPCC: a study by laser-assisted microdissection. 44
Single sperm cell isolation by laser microdissection 44
LMD as a forensic tool in a sexual assault casework: LCN DNA typing to identify the responsible 43
Microsatellite analysis in adenomas presenting in patients affected by HNPCC: a study by laser-assisted microdissection 43
Letter to the editor regarding: A comparative study of glial fibrillary acidic protein (GFAP)-like immunoreactivity in the retinas of some representative vertebrates. 43
Immunohistochemical demonstration of lactoferrin in human neoplastic tissues. 43
Lactoferrin immunoexpression in endometrial carcinomas: Relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival 43
Molecular and clinical analysis of predictive biomarkers to anti-EGFR inhibitors in metastatic colorectal cancer (mCRC): Interaction among early tumor shrinkage, skin toxicities, and RAS status. 43
Le cheratosi attiniche. Classificazione istopatologica. 43
The AgNOR count in ulcerative colitis with and without dysplasia 42
Immunohistochemical evidence of metallothionein in choroidal melanomas. 42
The AgNOR quantity as new promising prognostic tool in pathology of parathyroid glands. 42
Epidemiological and biomolecular characteristics of subcentimetric invasive breast carcinoma: a comparison between two different cohorts in southern Italy 42
KRAS mutation testing on different areas of primary colorectal adenocarcinomas with mucinous component 42
Totale 5.577
Categoria #
all - tutte 31.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.444

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 0 8
2019/20201.484 260 116 8 108 17 154 172 174 22 177 261 15
2020/20211.238 159 16 272 87 70 136 24 136 24 154 106 54
2021/20221.193 11 137 17 32 25 18 50 45 18 291 180 369
2022/20233.203 254 246 120 311 262 348 51 174 1.285 26 88 38
2023/2024661 76 123 51 97 51 166 17 24 4 25 3 24
Totale 8.537